Ollin Biosciences Launches with $100 Million Financing to Advance Next-Generation Ophthalmology Therapies Ollin Biosciences, Inc., a newly established clinical-stage biopharmaceutical company, announced its launch with an initial $100 million financing round led by ARCH Venture Partners, Mubadala Capital, and Monograph…
Tasca Therapeutics Doses First Patient in Phase 1/2 Clinical Trial of CP-383 for Advanced Solid Tumors Tasca Therapeutics, a clinical-stage biotechnology company dedicated to developing targeted therapies for genetically defined cancers, announced today that the first patient has been dosed…
Ionis Pharmaceuticals, Inc. marked a major milestone today, celebrating the 10th anniversary of Surf Away+, its signature adaptive community event. What began as an initiative to provide people with spinal muscular atrophy (SMA) access to adaptive surfing has evolved into…
Westlake Chemical Partners LP (NYSE: WLKP) (the “Partnership”) today reported net income attributable to the Partnership in the second quarter of 2025 of $14.6 million, or $0.41 per limited partner unit, which was in line with second quarter 2024 net…
A large gathering of 2’215 shareholders followed the invitation to the 62nd Annual General Meeting of EMS-CHEMIE HOLDING AG at Domat/Ems on August 9, 2025. A total of 20’467’468 registered shares were represented, corresponding to 92.9% of all shares entitled to vote. The…
The Surface Treatment global business unit of BASF’s Coatings division, operating under the Chemetall brand, has been selected to supply innovative PET recycling washing solutions for Circular Plastics Company’s new plastic recycling plant in Vung Tau, Vietnam. Chemetall will provide a…
AIS and GC are entering their third year of collaboration to further their environmental and sustainability missions with the “Green University: Throw, Turn, Let the World Remember Upvel 3” project . Held for the third consecutive year, the project aims to raise awareness of the waste…
Westlake Chemical Partners LP (NYSE: WLKP) (the “Partnership”) today reported net income attributable to the Partnership in the second quarter of 2025 of $14.6 million, or $0.41 per limited partner unit, which was in line with second quarter 2024 net…
Chevron Reports Second Quarter 2025 Financial Results: Highlights Production Milestones and Strategic Growth Chevron Corporation today announced financial results for the second quarter of 2025, reporting earnings of $2.5 billion, or $1.45 per diluted share. This compares to $4.4 billion,…
Evonik Appoints Guido Skudlarek as New Head of Health Care Business Line, Marking a Strategic Move in Global Health and Life Sciences Innovation Evonik Industries AG, a global leader in specialty chemicals, has announced the appointment of Dr. Guido Skudlarek…
Avantor Reports Q2 2025 Results, Highlights Resilience Amid Market Challenges and Announces CEO Transition Avantor,a leading global provider of mission-critical products and services to customers in the life sciences and advanced technology sectors, today announced its financial results for the…
LyondellBasell Reports Second Quarter 2025 Financial Results, Highlights Progress on Strategic Initiatives Amid Market Recovery LyondellBasell Industries , a global leader in the chemical and plastics industries, announced its financial and operational results for the second quarter of 2025. The…